Skip to main content
Discovering the causes of cancer and the means of prevention
 

Infections and Immunoepidemiology Fellowship Opportunities

Investigators in the Infections and Immunoepidemiology Branch (IIB) work with fellows to study the role of infectious agents and immune function in cancer risk. In collaboration with laboratory scientists, clinicians, and statisticians, IIB conducts multidisciplinary research studies nationally and internationally. In addition to epidemiologic and clinical data, many IIB field studies include extensive biological specimen collection that allows for careful molecular testing to better define both exposures and outcomes of interest. Descriptive epidemiology studies aimed at quantifying and explaining national and international trends in cancer incidence and mortality are also a focus. This work includes studies of:

  • People living with HIV/AIDS 
  • Organ transplant recipients
  • HPV vaccination and natural history 
  • Factors of etiological and immunologic relevance 
  • Natural history of infection-related malignancies 

Learn more about the Infections and Immunoepidemiology Branch research areas.

Apply to be a Fellow in IIB

Candidates must hold a degree in epidemiology, medicine, or a related field. Individuals with strong quantitative skills are encouraged to apply. Familiarity with infectious diseases, immunology, and/or cancers associated with infectious agents is also desirable.

Postdoctoral, predoctoral and postbaccalaureate fellowship applications are accepted on a continuous basis. Contact investigators in IIB doing research in your area of interest with a copy of your CV; DCEG scientists are always on the lookout for new trainees. In addition, submit your CV to the application database so it can be reviewed by investigators across the NCI searching for trainees. You can also apply for training positions with specific investigators listed below.

Training Opportunities with Specific Investigators

To explore training opportunities in other research areas, see a full list of the DCEG research groups on Apply for Fellowships page.

We know that transgender individuals have poorer health outcomes due to discrimination and stigma, however there’s very little known about the health risks in this population. Gender identity is not accurately captured in current cohorts or national surveys. In addition, the field of epidemiology is starting to recognize the influence of sex and gender differences on health including incidence of disease, response to treatment and survival—it’s important to tease apart these differences.

Sarah Jackson, Ph.D., M.P.H.

  • Updated:

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “Infections and Immunoepidemiology Fellowship Opportunities was originally published by the National Cancer Institute.”